All the datasets and pieces of code analysed and generated during the current study are available in a public github repository, at https://github.com/rduchesn/Dynamic_Model_Erythropoiesis.
Solutions of the dynamic models
Here, we give the solutions of the three dynamic models presented in systems (1) to (3) of the main text, which are represented graphically in figure 2 . In all the following, we will note Y 0 the initial condition at time t = 0 for variable Y .
SB model
System (1) is written in matrix form as:
S(t) B(t) .
We thus have immediate access to the eigenvalues of the system, and can solve it analytically. There are two possible cases, whether the two eigenvalues of the matrix are equal or not.
The dynamics of the self-renewing cells are described by the equation:
Concerning the dynamics of the differentiated cells, we thus have :
Then, there are two cases depending on the value of ρ B :
1. If ρ B = ρ S − δ SB , then B writes as:
B(t) = b 1 e ρ B t + b 2 e (ρ S −δ SB )t ,
2. If ρ B = ρ S − δ SB , then B writes as:
with b 2 = δ SB S 0 and b 1 = B 0 .
S2B model
System (2) is written in matrix form as:
Again, the eigenvalues of the matrix of the system are its diagonal coefficients. The dynamics of the self-renewing cells still follow an exponential dynamic:
and the differentiated cells follow the same dynamics as in the SB model (by replacing ρ S by ρ DM17 ).
SCB model
System (3) is written in matrix form as:
Again, the eigenvalues of the matrix of the system are its diagonal coefficients, and we can solve it analytically. There are several possible cases, depending on what eigenvalues are equal.
For the self-renewing cells, we have the same solution as in the two other models:
Concerning the dynamics of the committed cells, we thus have :
There are two cases depending on the respective values of ρ C − δ CB and ρ S − δ SC :
1. If ρ C − δ CB = ρ S − δ SC , then C writes as:
2. If ρ C − δ CB = ρ S − δ SC , then C writes as:
with c2 = δ SC S 0 and c 1 = C 0 .
Depending on the two previous cases, there are several possible solutions for the dynamics of differentiated cells:
Then, there are three possible sub-cases depending on the relative values of ρ S − δ SC , ρ C − δ CB and ρ B :
then B writes as:
Then, there are two possible sub-cases depending on the relative values of ρ S − δ SC , ρ C − δ CB and
(a) If ρ S − δ SC = ρ C − δ CB and ρ B = ρ S − δ SC , then B writes as:
and b1 = B 0
Convergence of the estimation
In both estimation steps, we minimized the -log likelihood with the Truncated Newton's algorithm implemented in scipy, with a maximum number of function evaluations of 10 6 . We used random sampling of the initial guesses for parameter values to assure convergence to the global optimum. Figure S1 shows the distance to the minimal log-likelihood (sorted from highest to lowest) over large samples of initial guesses (200 initial guesses for the first step, 1000 initial guesses for the second one) for our SCB model with proportional error. It shows that with a relatively small sample, the estimated likelihood is already quite close to its minimal value and that increasing the sample size doesn't result in a better fit.
In order to balance the quality of the fit with the computational cost of the estimation, we used 100 different initial guesses for the first estimation step and 500 initial guesses for the second one for all of our models. 
Parameter values
The estimated parameter values for the 9 pairs of dynamic and error models are displayed in table S1
Dynamic Error Table S1 : Best-fit estimates of the parameters for the 9 pairs of error model and dynamic model. ρ 1 is the net proliferation rate of the first compartment of the model (i.e. ρ S for the SB and SCB models, and ρ LM1 for the S2B model). δ 1 is the differentiation rate of this compartment (i.e. δ SB for the SB model, δ SC for the SCB model, and it is not defined for the S2B model). ρ 2 is the net proliferation rate of the second compartment, when it is different from the B compartment (i.e. ρ DM17 for the S2B model, ρ C for the SCB model, and it is not defined for the SB model). δ 2 is its differentiation rate (i.e. δ SB for the S2B model, δ CB for the SCB model, and it is not defined for the SB model). ρ B is defined in every model as in the SCB model. 
Importance of δ SC
In the estimation procedure described in the Methods section, every parameter of the dynamic model is estimated according to the experimental data, except δ SC , which is set to an arbitrary value between its two bounds (determined from the commitment experiment pictured on figure 1C ). Though these bounds give precise limits to the values that δ SC can take, setting it to different values might result in different optimal parameter values for the second estimation step of the procedure. Figure S2 displays the likelihood of the second estimation step for the range of values that δ SC can take. It does not vary significantly in this range, which means that the quality of the fit of the model is not influenced by the choice of the value of δ SC . This leaves two possible scenarios: either the value of δ SC has no influence on the estimated parameter values in the second estimation step, or it is possible to keep the likelihood high while changing the value of δ SC by adjusting the value of the other parameters (which would be a case of non-identifiability if the value of δ SC was optimized to fit the data). Figure S3 displays the values of the parameters estimated in the step 3 of the procedure, for the range of values that δ SC can take. Since these value do not vary much, it seems reasonable to say that the choice of the value of δ SC does not impact the last estimation step of the procedure. Figure S4 displays the profile likelihood curves for the parameters that are affected by the rapamycin treatment. In the model of rapamycin treatment that we selected, b 1 does not vary, so its value is not estimated from the data. It is also the case for δ SC , as in the control situation. It is thus impossible to define a profile likelihood for these two parameters. Thus, ρ S is now the only parameter that is estimated with the LM1 data, so its identifiability threshold is χ 2 (0.95, 1) = 3.84. The other parameters (ρ C , δ CB , ρ B and b 2 ) are all estimated together, so their identifiability threshold is χ 2 (0.95, 4) = 9.49, as in the control case. Figure S4 : The values of the parameters under rapamycin treatment are identifiable. For each of the parameters which varied under the treatment, the solid line represents the profile likelihood with respect to that parameter, and the dashed line gives the χ 2 identifiability threshold (at α = 0.95).
Identifiability of the treatment parameters

